AGEN · Agenus Inc
$7.32
+0.32 (+4.57%)
At close · Aug 14
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the timing and completion of these transactions are not entirely within our control, in accordance with applicable accounting standards, substantial doubt exists about our ability to continue as a going concern for at least one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 7, 2026
Market Cap
$329.55M
Shares
45.02M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $1,350,325 |
| Steven O’Day | Chief Medical Officer | $902,820 |
| Christine Klaskin | Vice President, Finance | $332,019 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $3,717,621 |
| Steven O’Day | Chief Medical Officer | $968,491 |
| Christine Klaskin | Vice President, Finance | $483,477 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $5,856,319 |
| Steven O’Day | Chief Medical Officer | $1,435,980 |
| Christine Klaskin | Vice President, Finance | $712,747 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $5,626,310 |
| Steven O’Day | Chief Medical Officer | $1,311,248 |
| Christine Klaskin | Vice President, Finance | $628,125 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $9,757,448 |
| Jennifer S. Buell | Former President and Chief Operating Officer | $7,415,240 |
| Steven O’Day | Chief Medical Officer | $2,372,735 |
| Adam Krauss | Former Chief Legal Officer and Chief Compliance Officer | $875,448 |
| Christine Klaskin | Vice President, Finance | $574,832 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $5,637,244 |
| Jennifer S. Buell | Former President and Chief Operating Officer | $2,829,910 |
| Evan D. Kearns | Vice President and General Counsel | $923,366 |
| Christine Klaskin | Vice President, Finance | $507,705 |
| Adam Krauss | Former Chief Legal Officer and Chief Compliance Officer | $454,663 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $9,937,038 |
| Jennifer S. Buell | Former President and Chief Operating Officer | $2,385,369 |
| Evan D. Kearns | Vice President and General Counsel | $1,610,578 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Garo H. Armen | Chief Executive Officer | $2,567,842 |
| Jennifer S. Buell | President and Chief Operating Officer | $986,467 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marco Tullio Marcucci | Class II director | Appointed | 2026-08-11 |
| Austin Charette | Principal Accounting Officer | Resigned | 2026-05-15 |
| Austin Charette | Principal Accounting Officer | Appointed | 2026-01-14 |
| Dr. Garo Armen | interim Chief Financial Officer and Principal Financial Officer | Appointed | 2026-01-14 |
| Ulf Wiinberg | director | Resigned | 2024-11-05 |
| Thomas L. Harrison | Class III director | Appointed | 2024-08-08 |
| Dr. Jennifer Buell | Board of Directors | Appointed | 2024-06-17 |
| Wadih Jordan | director | Retired | 2022-12-23 |
Key facts
CIK
1098972
CUSIP
00847G804
13F (30d)
107 filings
104 filers
Visit website
Investor relations